HOUSTON--(BUSINESS WIRE)--Jan. 4, 2006--CytoGenix, Inc. (OTCBB:CYGX) announced positive results of an animal study designed and conducted by the laboratory of Dr. David Weiner at the University of Pennsylvania Medical School Philadelphia. These tests demonstrated that a CytoGenix technique for generating synthetic DNA vaccines called synDNA(TM) as an smallpox vaccine, was highly potent in generating an immune response.
